Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Digitalis Ventures is a venture capital firm established in New York City, dedicated to addressing unmet needs in health. Founded to support early-stage companies, the firm focuses on life sciences, health technologies, and animal health. Digitalis Ventures is part of the Digitalis Group, which also encompasses Digitalis Research and Digitalis Commons.
The firm operates from its office at 11 Times Square, Suite 1500A, New York, NY 10036. Digitalis Ventures emphasizes a multidisciplinary approach, leveraging a diverse team and an expansive network of entrepreneurs, technical experts, research institutions, and financial partners to assist its portfolio companies throughout their development.
While specific metrics such as assets under management (AUM) and fund sizes are not disclosed, the firm is known for its commitment to supporting innovations that enhance health outcomes and improve access to care.
Digitalis Ventures invests primarily in biotechnology and technology-enabled health solutions, targeting early-stage companies that utilize breakthrough science to enhance human health. The firm is particularly interested in innovations that improve access to care and health outcomes while simultaneously reducing costs. This investment strategy encompasses a range of sectors, including life sciences, health technologies, and animal health.
In addition to its core focus on human health, Digitalis Ventures operates Companion Funds, which specifically target companies that leverage science, technology, and design to improve animal health. The firm’s investment stages range from pre-seed to Series A, primarily within North America. Digitalis Ventures seeks founders who demonstrate a strong vision and commitment to addressing significant health challenges.
Digitalis Ventures has a diverse portfolio that includes companies focused on both human and animal health. In the human health sector, notable investments include:
In the animal health sector, Digitalis Ventures has invested in:
Geoffrey W. Smith: Founder / Managing Partner. Geoffrey has extensive experience in venture capital and has led numerous successful investments in the health sector.
Misti Ushio: Managing Partner. Misti brings a wealth of knowledge in health technologies and has a strong background in supporting early-stage companies.
Samuel Bjork: Partner. Samuel specializes in biotechnology investments and has a track record of identifying promising health innovations.
Amit Bansal: Partner. Amit has expertise in operational support and strategic guidance for portfolio companies.
Ben Jacobs: Partner. Ben focuses on technology-enabled health solutions and has a background in health services.
Drew Taylor: Venture Partner. Drew provides insights into market trends and helps guide investment strategies.
Dac Nguyen: Technical Partner. Dac offers technical expertise to support portfolio companies in their development phases.
Cindy Cole: Technical Partner. Cindy collaborates with startups to enhance their technological capabilities.
Travis Hughes: Principal. Travis is involved in sourcing new investment opportunities and supporting portfolio growth.
Lauren Holtvoigt: Associate. Lauren assists in due diligence and portfolio management.
Michael Fall: Associate. Michael focuses on research and analysis to support investment decisions.
Bo Stewart: Associate. Bo is involved in operational support for portfolio companies.
Haiming Chen: Senior Accounting Manager. Haiming manages financial operations within the firm.
Dylan Henderson: Accounting Manager. Dylan supports the financial management of the firm.
Steve Allen: Emeritus Partner. Steve provides strategic insights based on his extensive experience in venture capital.
To pitch Digitalis Ventures, founders should visit their website at digitalisventures.com. It is recommended to include a detailed pitch deck that outlines the business model, market opportunity, and the team’s expertise. Digitalis Ventures prefers pitches that clearly demonstrate how the startup addresses unmet health needs.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
Digitalis Ventures collaborates with Michelsen Found Animals and R/GA Ventures to operate the Leap Venture Studio. This accelerator program is designed for early-stage companies in the animal health sector, providing resources, mentorship, and networking opportunities to help startups succeed.
In recent months, Digitalis Ventures has continued to expand its portfolio in the health sector. Notable investments include companies focused on biotechnology and technology-enabled health solutions. The firm has also been active in supporting its existing portfolio companies through operational guidance and strategic insights.
Digitalis Ventures has maintained its commitment to animal health innovations through its Companion Funds, collaborating with partners like Mars Petcare to enhance the health and well-being of pets.
What are Digitalis Ventures' investment criteria?
Digitalis Ventures focuses on early-stage companies in biotechnology and technology-enabled health solutions. They seek innovations that enhance human health and improve access to care while reducing costs. The firm also invests in animal health through its Companion Funds.
How can I pitch Digitalis Ventures?
Founders can pitch Digitalis Ventures through their website at digitalisventures.com. It is advisable to include a clear overview of the business model, market opportunity, and how the solution addresses unmet health needs.
What makes Digitalis Ventures different from other investors?
Digitalis Ventures distinguishes itself through its focus on both human and animal health, leveraging a multidisciplinary team and a vast network of experts to support portfolio companies. Their Companion Funds specifically target innovations in animal health, providing a unique dual focus.
What is the geographic scope of Digitalis Ventures?
The firm primarily invests in North America, focusing on early-stage companies that align with their investment thesis in health innovation.
What is the typical check size for investments?
While specific check sizes are not disclosed, Digitalis Ventures invests at the pre-seed, seed, seed-plus, and Series A stages, indicating a range that typically aligns with early-stage funding rounds.
What kind of post-investment involvement can founders expect?
Digitalis Ventures provides operational support, mentorship, and access to their extensive network of entrepreneurs and technical experts to help portfolio companies grow and succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.